
Interview on the challenges of implementing artificial intelligence in clinical practice
Interview about AI use in healthcare, where challenges such as implementation, the 'pilot graveyard' and the risk of unauthorized use of AI tools, so-called shadow AI, are discussed from the Karolinska Institute's perspective.
AI-generated summary
Karolinska Institutet has established the Center for AI Innovation to support researchers with methodology and law around AI use.
How is AI used in healthcare today?
- Very different. Some researchers and clinicians are curious, but unsure, others are already very advanced users. Since I came to Karolinska Institutet in January 2020, my mission has been to map out who does what and how to support each other. It is clear that interest is growing rapidly, but also that the needs for support look very different.
What is the biggest obstacle?
- Getting from prototype to real use. Many come up with solutions that work well in tests and that everyone thinks seem promising. But when they are to be introduced in care, it will be a long drawn out process. It requires permission, certification and a clinical introduction, which takes time. The risk is that the solution is out of date already when it is ready.
Is that what is called the pilot graveyard?
- Yes. That's where projects end up that work, that have been tested and validated, but that still never start being used clinically. It's quite tragic. Care misses out on good ideas because the last step is not completed.
Why does that happen?
- Often because the introduction is not sufficiently anchored in the business. It is not enough that the technology works. The clinic must have time, resources and a clear need. Otherwise, the project gets bogged down just before it could do any good.
You also warn about shadow AI. What is it and how big is the problem?
- Probably bigger than many people think. Employees use AI tools at work without being approved by the employer. This could be medical records, patient information or medical images. It worries both management and lawyers, as it can violate confidentiality and regulations.
Why does Karolinska Institutet need a Center for AI Innovation and the initiative AI@KI?
- To gather skills that are otherwise scattered. We wanted to create a common entrance for KI's researchers, where they can get help with both methodology, law and what is actually permitted. In short: Come to us and we will help you.
How big is the potential for AI in healthcare?
- It is very large. AI is already used in image diagnostics, for example in X-ray, magnetic resonance and computed tomography. The technology can contribute to sharper images and better decision support. But it's also about control: how much you want to buy ready-made and how much you want to develop yourself to ensure that the solutions really meet the needs of healthcare.
What risks do you see?
- That the staff become too dependent on the systems. If AI services suddenly stop working, the clinician must still be able to do the job. Studies show that things we don't use regularly weaken. In healthcare, it can become a patient safety problem.

Cecilia, 52, was diagnosed with aggressive breast cancer in the summer of 2023. Through Capio St. Göran's hospital's AI-supported screening, the tumor was detected early. Today, she is cancer-free but reflects on the fragility of life and the new everyday life after the treatment.
One patient had to wait months for a return visit that would take place after a few weeks. When care was finally contacted, a total retinal detachment was discovered and the vision could not be saved. The incident is reported according to Lex Maria.

A Nordic study with 3,500 patients shows that aspirin can halve the risk of colon and rectal cancer recurrence in patients with a certain gene mutation. The discovery has led to new recommendations in the national care program.

The author describes his personal experiences of trying to book an annual skin check through the 1177 care system and encountering obstacles such as changed booking rules, missed calls and automatic messages saying the case is closed even though the problem remains. The text criticizes the bureaucratic handling of care contacts and compares it to similar systems in the workplace where cases can be closed without the user's consent.
Tobiasregistret, Sweden's registry for blood stem cell donors, reports that the chance of finding a suitable donor is 70 percent among all patients, but only between 10 and 30 percent for patients with a non-European background. The registry is calling for more donors with non-European background as well as more guys to increase the matching possibilities, as the tissue type is inherited and crucial to the success of the transplant.
The authority for health and care analysis has mapped the rapidly growing market for privately funded investigations and treatments for ADHD and autism. Turnover has increased by 300 percent in six years for healthcare providers with only private funding. The authority warns of problematic marketing on social media that may conflict with the Medical Association's rules and influence the decisions of vulnerable patients. Many private actors do not report data to the National Board of Health and Welfare's patient register, which makes quality comparisons with public care difficult. The final report is expected in a year.